Perlmutter Cancer Center Continues to Grow in Brooklyn
NYU Langone Health’s Perlmutter Cancer Center opens its fourth location in Brooklyn and significantly expands services this year in the borough.
Perlmutter Cancer Center Earns Comprehensive Status
Perlmutter Cancer Center has been designated a Comprehensive Cancer Center, the highest ranking awarded by the National Cancer Institute.
Perlmutter Cancer Center Earns Elite Recognition
Dr. Benjamin G. Neel explains how top recruits and a revamped clinical trials program have transformed NYU Langone’s Perlmutter Cancer Center.
Perlmutter Cancer Center Expands Cancer Care to Sunset Park
NYU Langone’s Perlmutter Cancer Center opens the doors to a new, multispecialty, outpatient cancer facility in Sunset Park, Brooklyn.
Perlmutter Cancer Center Expands Clinical Trials Portfolio
Despite the challenges brought with the COVID-19 pandemic, 2020 was another year of growth for Perlmutter Cancer Center’s clinical trials program.
Perlmutter Cancer Center Expands Clinical Trials Program
Perlmutter Cancer Center’s clinical trials program has grown due to an expanded phase I portfolio, biobanking, and other initiatives.
Perlmutter Cancer Center Expands Services on Long Island
With NYU Langone Health and NYU Winthrop Hospital’s merger, Perlmutter Cancer Center’s services expand on Long Island.
Perlmutter Cancer Center Expands to Long Island
NYU Langone’s Perlmutter Cancer Center expands clinical and research activities on Long Island, opening of a new facility in Huntington.
Perlmutter Cancer Center Hosts Immunotherapy Patient Summit
Experts from NYU Langone’s Perlmutter Cancer Center informed cancer patients, caregivers, and advocates of new breakthroughs in immunotherapy.
Perlmutter Cancer Center Institutional Profile
NYU Langone medical oncologist Dr. Catherine S. Diefenbach discusses clinical trials supported by the ECOG-ACRIN cooperative group.